08:48pm Sunday 22 October 2017

HPV Vaccination of Adolescent Boys May Be Cost-Effective for Preventing Oropharyngeal Cancer

Many western countries have established female HPV vaccination programs for preventing cervical cancer. Little is known about the cost-effectiveness of male-HPV vaccination, however. Donna Graham, MB, BCh, MRCPUK and Lillian Siu, MD, FRCPC, of the Princess Margaret Cancer Centre, University Health Network, in Toronto, led a team that compared the potential costs and effectiveness of vaccinating adolescent boys in Canada against HPV for preventing HPV-related oropharyngeal cancer. When the investigators applied a statistical model to a population of 192,940 Canadian boys who were 12 years old in 2012, they found that HPV vaccination could save from $8 million to $28 million Canadian dollars over the boys’ lifetimes. Factors that could impact the cost savings of HPV vaccination in boys include, among others, vaccine cost, vaccine effectiveness, costs of cancer treatment, and survival of patients with HPV-related oropharyngeal cancers.

“We believe this study is important because HPV-related oropharyngeal cancer has increased significantly in incidence, especially in developed countries,” said Dr. Graham. “It is projected that by 2020, HPV-related oropharyngeal cancer will become the most common HPV-related cancer in the US, surpassing cervical cancer.”

Policy makers in many countries such as the United States, Canada, Austria, and Australia have recommended HPV vaccination in boys, but it is unfunded and is excluded from national immunization programs in many countries worldwide, notes Dr. Siu. “We hope that results from this study would raise awareness and lead to further assessment of this important public health issue,” she said.

Media wishing to receive a PDF of this article may contact sciencenewsroom@wiley.com. (Would you prefer to access this paper instantly? You can register for a login to our Press Room here.)

Article: “A cost-effectiveness analysis of human papillomavirus vaccination of boys for the prevention of oropharyngeal cancer.” Donna M. Graham, Wanrudee Isaranuwatchai, Steven Habbous, Claire de Oliveira, Geoffrey Liu, Lillian L. Siu, and Jeffrey S. Hoch. CANCER; Published Online: April 13, 2015 (DOI: 10.1002/cncr.29111).

URL: http://doi.wiley.com/10.1002/cncr.29111

Author Contact: Jane Finlayson of the Princess Margaret Cancer Centre’s press office at +1 (416) 946-2846 or jane.finlayson@uhn.ca .

CANCER is a peer-reviewed publication of the American Cancer Society integrating scientific information from worldwide sources for all oncologic specialties. The objective of CANCER is to provide an interdisciplinary forum for the exchange of information among oncologic disciplines concerned with the etiology and course of human cancer. CANCER is published by Wiley and can be accessed online at http://wileyonlinelibrary.com/journal/cancer.

About Wiley
Wiley is a global provider of content-enabled solutions that improve outcomes in research, education, and professional practice. Our core businesses produce scientific, technical, medical, and scholarly journals, reference works, books, database services, and advertising; professional books, subscription products, certification and training services and online applications; and education content and services including integrated online teaching and learning resources for undergraduate and graduate students and lifelong learners.

Founded in 1807, John Wiley & Sons, Inc. (NYSE: JWa, JWb), has been a valued source of information and understanding for more than 200 years, helping people around the world meet their needs and fulfill their aspirations. Wiley and its acquired companies have published the works of more than 450 Nobel laureates in all categories: Literature, Economics, Physiology or Medicine, Physics, Chemistry, and Peace. Wiley’s global headquarters are located in Hoboken, New Jersey, with operations in the U.S., Europe, Asia, Canada, and Australia. The Company’s website can be accessed at http://www.wiley.com.

Media Contacts:
Evelyn Martinez (US) +1 201 748 6358
Tom Griffin (UK) +44 (0) 1865 476213
sciencenewsroom@wiley.com


Share on:
or:

Health news